Swipe om te navigeren naar een ander artikel
Endometriosis presents with significant pain as the most common symptom. Generic health measures can allow comparisons across diseases or populations. However, the Medical Outcomes Study Short Form 36 (SF-36) has not been validated for this disease. The goal of this study was to validate the SF-36 (version 2) for endometriosis.
Using data from two clinical trials (N = 252 and 198) of treatment for endometriosis, a full complement of psychometric analyses was performed. Additional instruments included a pain visual analog scale (VAS); a physician-completed questionnaire based on patient interview (modified Biberoglu and Behrman—B&B); clinical global impression of change (CGI-C); and patient satisfaction with treatment.
Bodily pain (BP) and the Physical Component Summary Score (PCS) were correlated with the pain VAS at baseline and over time and the B&B at baseline and end of study. In addition, those who had the greatest change in BP and PCS also reported the greatest change on CGI-C and patient satisfaction with treatment. Other subscales showed smaller, but significant, correlations with change in the pain VAS, CGI-C, and patient satisfaction with treatment.
The SF-36—particularly BP and the PCS—appears to be a valid and responsive measure for endometriosis and its treatment.
Barton-Smith, P., Ballard, K., & Kent, A. S. H. (2006). Endometriosis: A general review and rationale for surgical therapy. Reviews in Gynaecological and Perinatal Practice, 6(3–4), 168–176. CrossRef
Plumb, K., Sinaii, N., Cotton, L., Zondervan, K., Treloar, S., Lambert, A., et al. (2005). Differences in characteristics of 1000 women with endometriosis based on disease severity. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 123(Suppl. 1), S5.
Gerety, E., & Harris, R. D. (2001). Endometriosis: Epidemiology, current pathophysiological concepts, and imaging considerations. Applied Radiology, 3, 11–18. CrossRef
Koninckx, P. R., Meuleman, C., Demeyere, S., Lesaffre, E., & Cornillie, F. J. (1991). Suggestive evidence that pelvic endometriosis is a progressive disease, whereas deeply infiltrating endometriosis is associated with pelvic pain. Fertility and Sterility, 55(4), 759–765. PubMed
Missmer, S. A. & Cramer, D. W. (2003). The epidemiology of endometriosis. Obstetrics and Gynecology Clinics of North America, 30(1), 1–19, vii.
Vigano, P., Parazzini, F., Somigliana, E., & Vercellini, P. (2004). Endometriosis: Epidemiology and aetiological factors. Best Practice & Research Clinical Obstetrics & Gynaecology, 18(2), 177–200. CrossRef
Mahmood, T. A., & Templeton, A. (1991). Prevalence and genesis of endometriosis. Human Reproduction, 6(4), 544–549. PubMed
Hummelshoj, L., Prentice, A., & Groothuis, P. (2006). Update on endometriosis. Womens Health (Lond Engl), 2(1), 53–56. CrossRef
Ballweg, M. L. (2004). Impact of endometriosis on women’s health: Comparative historical data show that the earlier the onset, the more severe the disease. Best Practice & Research Clinical Obstetrics & Gynaecology, 18(2), 201–218. CrossRef
Marques, A., Bahamondes, L., Aldrighi, J. M., & Petta, C. A. (2004). Quality of life in Brazilian women with endometriosis assessed through a medical outcome questionnaire. Journal of Reproductive Medicine, 49(2), 115–120. PubMed
Acquadro, C., Berzon, R., Dubois, D., Leidy, N. K., Marquis, P., Revicki, D., et al. (2003). Incorporating the patient’s perspective into drug development and communication: An ad hoc task force report of the patient-reported outcomes (PRO) Harmonization Group meeting at the Food and Drug Administration, February 16, 2001. Value Health, 6(5), 522–531. PubMedCrossRef
Bodner, C. H., Garratt, A. M., Ratcliffe, J., Macdonald, L. M., & Penney, G. C. (1997). Measuring health-related quality of life outcomes in women with endometriosis—results of the Gynaecology Audit Project in Scotland. Health Bulletin (Edinb), 55(2), 109–117.
Lyons, S. D., Chew, S. S., Thomson, A. J., Lenart, M., Camaris, C., Vancaillie, T. G., et al. (2006). Clinical and quality-of-life outcomes after fertility-sparing laparoscopic surgery with bowel resection for severe endometriosis. Journal of Minimally Invasive Gynecology, 13(5), 436–441. PubMedCrossRef
Miller, J. D. (2000). Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: A double-blind, randomized, placebo-controlled trial. American Journal of Obstetrics and Gynecology, 182(6), 1483–1488. PubMedCrossRef
Chassany, O., Le-Jeunne, P., Duracinsky, M., Schwalm, M. S., & Mathieu, M. (2006). Discrepancies between patient-reported outcomes and clinician-reported outcomes in chronic venous disease, irritable bowel syndrome, and peripheral arterial occlusive disease. Value Health, 9(1), 39–46. PubMedCrossRef
Ware, J. E., Kosinski, M., & Keller, S. K. (1994). SF-36 ® Physical and Mental Health Summary Scales: A User’s Manual. Boston, MA: The Health Institute.
Biberoglu, K. O., & Behrman, S. J. (1981). Dosage aspects of danazol therapy in endometriosis: Short-term and long-term effectiveness. American Journal of Obstetrics and Gynecology, 139(6), 645–654. PubMed
Guy, W. (1976). ECDEU assessment manual for psychopharmacology. Rockville, MD: U.S. Department of Health, Education, and Welfare.
Ware, J. E., Kosinski, M., & Dewey, J. E. (2000). How to score version two of the SF-36 health survey. Lincoln, RI: QualityMetric, Incorporated.
Kline, R. B. (2011). Principles and practice of structural equation modeling (3rd ed.). New York: The Guilford Press.
Browne, M. W., & Cudeck, R. (1993). Alternative ways of assessing model fit. In K. A. Bollen & J. S. Long (Eds.), Testing structural equation models (pp. 136–162). Newbury Park, CA: Sage.
Beivik, E., & Olsson, U. H. (2001). Adding variables to improve fit: The effect of model size on fit assessment in LISREL. In R. Cudeck, S. du Toit, & D. Sörbom (Eds.), Structural equation modeling: Present and future (pp. 169–194). Lincolnwood, IL: Scientific Software International.
Cohen, J. (1988). Statistical power analysis for the behavioral sciences (2nd ed.). Hillsdale, New Jersey: Erlbaum.
Ware, J. E., Kosinski, M., & Gandek, B. (2004). SF-36 Health Survey: Manual and Interpretation Guide. Lincoln, RI: Quality Metric Incorporated.
Gerlinger, C., Schumacher, U., Faustmann, T., Colligs, A., Schmitz, H., & Seitz, C. (2010). Defining a minimal clinically important difference for endometriosis-associated pelvic pain measured on a visual analog scale: Analyses of two placebo-controlled, randomized trials. Health and Quality of Life Outcomes, 8, 138. http://www.hqlo.com/content/8/1/138.
Butterworth, P., & Crosier, T. (2004). The validity of the SF-36 in an Australian National Household Survey: Demonstrating the applicability of the Household Income and Labour Dynamics in Australia (HILDA) Survey to examination of health inequalities. BMC Public Health, 4, 44. PubMedCentralPubMedCrossRef
- Validation of the SF-36 in patients with endometriosis
Donald E. Stull
- Springer International Publishing